Kinesin family member 11 is also known as Kinesin-5, which has been widely studied for its role in mitosis and the potential as a therapeutic target in the treatment of cancer.[69] Inhibitors of KIF11 have been developed as chemotherapeutic agents for cancer treatment.[70] Pei et al[71] indicated that KIF11 contributes to the progression and prognosis of human BC. Here, KIF11 is linked to breast cancer.